Multiple steroid hormone receptors in normal and abnormal human endometrium

Area of Science:

• Gynecology
• Endocrinology
• Oncology

Background:

• Steroid hormone receptors, including estrogen receptor (ER), androgen receptor (AR), progesterone receptor (PR), and glucocorticoid receptor (GR), play crucial roles in endometrial tissue function and disease.
• Understanding the expression patterns of these receptors in normal and abnormal endometrium is vital for developing targeted therapies.

Purpose of the Study:

• To determine the cytoplasmic concentrations of ER, AR, PR, and GR in normal and abnormal endometrial and uterine tissues.
• To investigate the impact of hormone treatment (MAP) on receptor levels in endometrial carcinoma.
• To explore correlations between receptor presence, tumor grade, and hormone treatment status.

Main Methods:

• Cytoplasmic receptor concentrations were measured using the DCC (dextran-coated charcoal) technique.
• Analysis was performed on 124 specimens of normal and abnormal human endometrium and uterine tissues.
• Hormone-untreated and pretreated (MAP) endometrial carcinoma groups were compared.

Main Results:

• In endometrial carcinoma pretreated with MAP, low cellularity and higher AR levels were observed, with decreased ER, GR, and PR. PR was frequently absent.
• A positive correlation was found between ER presence and tumor differentiation grade in hormone-untreated endometrial tumors.
• In hormone-untreated cancer, single receptor frequencies ranged from 61% to 88%. ER and PR were co-present in 55% of cases, ER-AR-PR in 45%, and all four receptors in 40%.

Conclusions:

• Hormone pretreatment significantly alters steroid hormone receptor profiles in endometrial carcinoma.
• Estrogen receptor status is linked to the differentiation grade of endometrial tumors in untreated patients.
• Receptor expression levels in normal endometrium from hormone-untreated patients were generally higher than in cancerous tissues.